健康管理人群代谢综合征发病风险预测模型
A prediction model for metabolic syndrome risk: a study based on the health management cohort

DOI: 10.6040/j.issn.1671-7554.0.2017.350

Keywords: 代谢综合征,健康管理人群,Cox比例风险回归,纵向队列,风险预测模型,
Health management population,Metabolic syndrome,Longitudinal cohort,Prediction model,Coxs proportional hazards regression

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]	Beltrán-Sánchez H, Harhay MO, Harhay MM, et al. Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999-2010[J]. J Am Coll Cardiol, 2013, 62(8): 697-703.
[2]	Gu D, Reynolds K, Wu X, et al. Prevalence of the metabolic syndrome and overweight among adults in China[J]. Lancet, 2005, 365(9468): 1398-1405.
[3]	Kaur J. A comprehensive review on metabolic syndrome[J]. Cardiol Res Pract, 2014, 2014:943162. doi:10.1155/2014/943162.
[4]	Hsiao FC, Wu CZ, Hsieh CH, et al. Chinese metabolic syndrome risk score[J]. South Med J, 2009, 102(2): 159-164.
[5]	Jiang B, Li B, Wang Y, et al. The nine-year changes of the incidence and characteristics of metabolic syndrome in China: longitudinal comparisons of the two cross-sectional surveys in a newly formed urban community[J]. Cardiovasc Diabetol, 2016, 15:84. doi: 10.1186/s12933-016-0402-9.
[6]	Sheu WH, Chuang SY, Lee WJ, et al. Predictors of incident diabetes, metabolic syndrome in middle-aged adults: a 10-year follow-up study from Kinmen, Taiwan[J]. Diabetes Res Clin Pract, 2006, 74(2): 162-168.
[7]	Yu S, Guo X, Yang H, et al. An update on the prevalence of metabolic syndrome and its associated factors in rural northeast China[J]. BMC Public Health, 2014, 14: 877. doi: 10.1186/1471-2458-14-877.
[8]	Li G, de Courten M, Jiao S, et al. Prevalence and characteristics of the metabolic syndrome among adults in Beijing, China[J]. Asia Pac J Clin Nutr, 2010, 19(1): 98-102.
[9]	Ford ES. The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study[J]. Atherosclerosis, 2004, 173(2): 309-314.
[10]	Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement[J]. Circulation, 2005, 112(17): 2735-2752.
[11]	Wilson PW, D'Agostino RB, Parise H, et al. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus[J]. Circulation, 2005, 112(20): 3066-3072.
[12]	Lu J, Wang L, Li M, et al. Metabolic syndrome among adults in China - the 2010 China noncommunicable disease surveillance[J]. J Clin Endocrinol Metab, 2017, 102(2): 507-515.
[13]	Park YW, Zhu S, Palaniappan L, et al. The metabolic syndrome: Prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994[J]. Arch Intern Med, 2003, 163(4): 427-436.
[14]	Li JB, Wang X, Zhang JX, et al. Metabolic Syndrome: prevalence and risk factors in southern China[J]. J Int Med Res, 2010, 38(3): 1142-1148.
[15]	Dai X, Yuan J, Yao P, et al. Association between serum uric acid and the metabolic syndrome among a middle- and old-age Chinese population[J]. Eur J Epidemiol, 2013, 28(8): 669-676.
[16]	中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2013年版)[J]. 中华内分泌代谢杂志, 2014, 30(10): 26-89. Chinese Diabetes Society. China guideline for type 2 diabetes[J]. Chin J Endocrinol Metab, 2014, 30(10): 26-89.
[17]	Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey[J]. JAMA, 2002, 287(3): 356-359.
[18]	Xiao J, Wu CL, Gao YX, et al. Prevalence of metabolic syndrome and its risk factors among rural adults in Nantong, China[J]. Sci Rep, 2016, 6: 38089. doi: 10.1038/srep38089.
[19]	Kassi E, Pervanidou P, Kaltsas G, et al. Metabolic syndrome: definitions and controversies[J]. BMC Med, 2011, 9: 48. doi: 10.1186/1741-7015-9-48.
[20]	Zhou XH, Song XX, Ji LN. The components of metabolic syndrome analyzed by factor analysis[J]. J Diabetes, 2005, 13(6): 434-436.
[21]	Yang XH, Tao QS, Sun F, et al. Setting up a risk prediction model on metabolic syndrome among 35-74 year-olds based on the Taiwan MJ Health-checkup Database[J]. Chin J Epidemiol, 2013, 34(9): 874-878.
[22]	中华医学会糖尿病学分会代谢综合征研究协作组. 中华医学会糖尿病学分会关于代谢综合征的建议[J]. 中华糖尿病杂志, 2004, 12(3): 156-161. Metabolic syndrome research collaboration group from Chinese Diabetes Society. Suggestions on metabolic syndrome from Chinese Diabetes Society[J]. Chin J Diabetes, 2004, 12(3): 156-161.
[23]	Regitz-Zagrosek V, Lehmkuhl E, Weickert MO. Gender differences in the metabolic syndrome and their role for cardiovascular disease[J]. Clin Res Cardiol, 2006, 95(3): 136-147.
[24]	Zhou P, Meng Z, Liu M, et al. The associations between leukocyte, erythrocyte or platelet, and metabolic syndrome in different genders of Chinese[J]. Medicine, 2016, 95(44): e5189. doi: 10.1097/MD.0000000000005189
[25]	Hwang LC, Bai CH, Chen CJ, et al. Gender difference on the development of metabolic syndrome: a population-based study in Taiwan[J]. Eur J Epidemiol, 2007, 22(12): 899-906.
[26]	Villegas R, Xiang YB, Yang G, et al. Prevalence and determinants of metabolic syndrome according to three definitions in middle-aged Chinese men[J]. Metab Syndr Relat Disord, 2009, 7(1): 37-45.
[27]	Tao LX, Li X, Zhu HP, et al. Association of hematological parameters with metabolic syndrome in Beijing adult population: a longitudinal study[J]. Endocrine, 2014, 46(3): 485-495.
[28]	Wang F, Wu S, Song Y, et al. Waist circumference, body mass index and waist to hip ratio for prediction of the metabolic syndrome in Chinese[J]. Nutr Metab Cardiovasc Dis, 2009, 19(8): 542-547.

Full-Text